Company
Dawnrays Pharmaceutical
Headquarters: Wan Chai, Hong Kong
Employees: 1,065
Market Cap
HK$1.66 Billion
HKD as of Jan. 1, 2024
US$213.2 Million
Dawnrays Pharmaceutical Categories
Hong Kong Healthcare Drug Manufacturers—Specialty & GenericHong Kong Healthcare Hong Kong Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. It offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics; and system specific medicines for various therapeutic areas comprising cardiovascular system, anti-allergic, anti-HBV, digestive system, urinary system, anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Dawnrays Pharmaceutical has the following listings and related stock indices.
Stock: HKEX: 2348 wb_incandescent